Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Johnson & Johnson to Pay $120M to Settle DePuy Hip Claims By U.S. States January 23, 2019 Irvin Jackson Add Your Comments Johnson & Johnson have agreed to pay $120 million to settle DePuy hip claims brought by several states, which accused the manufacturer of engaging in deceptive marketing by failing to warn the medical community and patients about the risk that metal-on-metal hip replacements had a propensity to fail and cause other complications. New York Attorney General Letitia James issued a press release on January 22, announcing the settlement between Johnson & Johnson, it’s DePuy Orthopaedics subsidiary, and 46 attorneys general nationwide, which resolve allegations stemming from the marketing practices for the Pinnacle Ultamet and ASR XL. The allegations focused specifically on statements about the purported longevity of the metal-on-metal hip implants. According to the lawsuits, DePuy advertised that the ASR XL had a survivorship rate of 99.2 percent at three years, and the Pinnacle Ultimate had a 99.9 percent survivorship at five years. However, the National Joint Registry of England and Wales reported that the ASR XL had a seven percent revision rate after three years, and the Pinnacle Ultamet failed 4.28 percent of the time within five years. Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “Doctors and their patients need to have accurate and up to date information to ensure that patients are receiving appropriate healthcare,” James said in the press release. “Companies should never be allowed to freely mislead the public, especially when there are health concerns involved. This settlement serves as an important message that deceptive and false medical practices will never be tolerated.” In addition to the $120 million settlement, DePuy has agreed to change its marketing for hip implants to base longevity statistics on recent registry data, maintain a post marketing surveillance program and a program to handle complaints. The complaints program would include a quality assurance aspect to ensure they are being handled properly, and would also include a quarterly review of complaints that would identify specific problems, determine the cause of those problems, and address them and its marketing of the implants appropriately. DePuy Pinnacle Hip Lawsuits The announcement comes a little more than a month after Johnson & Johnson agreed to settle more than 3,000 Depuy Pinnacle lawsuits filed by individuals nationwide whose hip implants failed, often requiring revision surgery. At the litigation’s peak, the company faced 10,000 product liability claims over Pinnacle failures and complications. The federal cases are centralized before U.S. District Judge Ed Kinkeade in the Northern District of Texas, as part of an MDL (multidistrict litigation) established in 2011. As part of the coordinated pretrial proceedings, a number of “bellwether” trials have gone before juries in recent years, with several resulting in massive damage awards of several hundred million dollars. In late 2017, a jury ordered Johnson & Johnson to pay six plaintiffs $247 million in damages. That verdict came after a $500 million jury award in March 2016 and a $1 billion award in December 2016. While the first award was later reduced to about $500 million, and the second award was reduced to $151 million under Texas state damage caps, the staggering verdicts provided a clear signal about how juries may respond if similar cases went to trial in the future.. Johnson & Johnson previously agreed to pay more than $2.4 billion to settle DePuy ASR metal hip lawsuits, which was a recalled hip system based on the design of the DePuy Pinnacle metal hip. Tags: DePuy, DePuy Pinnacle Hip, Hip Replacement System, Johnson & Johnsion, Metal-on-Metal Hip Implant More Hip Replacements Lawsuit Stories Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant December 26, 2024 Zimmer Biomet Lawsuit Filed Over RibFix Blu Implant Fracture September 25, 2024 Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)